Julia Haller, MD
Ophthalmology · Philadelphia, PANPI 1871542514
Payments from drug & device makers
Across 303 payments — averaging $5023.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$1.4M
- E.r. Squibb & Sons, L.L.C.$44K
- Regeneron$29K
- Genentech, Inc.$2K
- Bausch & Lomb Americas Inc.$1K
- Janssen Global Services, LLC$740
- plus $27 from 1 others
Across 9 payments — averaging $1735.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$16K
What the payments were for
- Consulting fees$29,7842%
- Speaking & faculty fees$1,188,91378%
- Travel & lodging$255,30817%
- Food & beverage$31,8272%
- Education$13,9581%
- Gifts$2,1520%
- Entertainment$750%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb(2 entities) | 231 | $1,445,145 |
| E.r. Squibb & Sons, L.L.C. | 40 | $44,069 |
| Regeneron | 17 | $28,878 |
| Genentech, Inc. | 3 | $1,695 |
| Bausch & Lomb Americas Inc. | 10 | $1,463 |
| Janssen Global Services, LLC | 1 | $740 |
| Alcon | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EYLEA$10,431
How this compares
$1,522,016 in reported general payments places this provider in the 95th percentile of 920 ophthalmology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 12 | $655 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Philadelphia
- Jonathan MyersPhiladelphia$660K
- Beeran MeghparaPhiladelphia$496K
- Cesar BricenoPhiladelphia$487K
- Mark BlecherPhiladelphia$357K
- Anton KolomeyerPhiladelphia$355K
- Leslie KatzPhiladelphia$159K
- Durga BorkarPhiladelphia$150K
- Bennie JengPhiladelphia$142K
- Rachel NiknamPhiladelphia$142K
- Joseph MarkoffPhiladelphia$130K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.